Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Simonetti

Showing results (71-80 of 78) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 78 results.
Annals of Neurology|April 1, 1992
MELAS: clinical features, biochemistry, and molecular geneticsE Ciafaloni, E Ricci, S Shanske, et al.
American Journal of Human Genetics|August 1, 1994
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidusD G Bichet, M Birnbaumer, M Lonergan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1992
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicityS Przedborski, V Kostic, V Jackson-Lewis, et al.
Histology and Histopathology|November 13, 2013
Schwannomas, benign tumors with a senescent phenotypeS Simonetti, C Serrano, J Hernández-Losa, et al.
Scientific Reports|September 2, 2017
A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancerL Gasa, A Sanchez-Botet, E Quandt, et al.
The American Journal of Cardiology|August 3, 2014
Preclinical left ventricular diastolic dysfunction in metabolic syndromeNir Ayalon, Deepa M Gopal, Deirdre M Mooney, et al.
Breast Cancer Research and Treatment|February 23, 2026
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysisL Sisca, M G Polito, M Silletta, et al.
Oncogene|August 28, 2024
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical modelsF Pantano, S Simonetti, M Iuliani, et al.
Pageof 8

Showing results (71-80 of 78) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 78 results.
Annals of Neurology|April 1, 1992
MELAS: clinical features, biochemistry, and molecular geneticsE Ciafaloni, E Ricci, S Shanske, et al.
American Journal of Human Genetics|August 1, 1994
Nature and recurrence of AVPR2 mutations in X-linked nephrogenic diabetes insipidusD G Bichet, M Birnbaumer, M Lonergan, et al.
The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|May 1, 1992
Transgenic mice with increased Cu/Zn-superoxide dismutase activity are resistant to N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced neurotoxicityS Przedborski, V Kostic, V Jackson-Lewis, et al.
Histology and Histopathology|November 13, 2013
Schwannomas, benign tumors with a senescent phenotypeS Simonetti, C Serrano, J Hernández-Losa, et al.
Scientific Reports|September 2, 2017
A systematic analysis of orphan cyclins reveals CNTD2 as a new oncogenic driver in lung cancerL Gasa, A Sanchez-Botet, E Quandt, et al.
The American Journal of Cardiology|August 3, 2014
Preclinical left ventricular diastolic dysfunction in metabolic syndromeNir Ayalon, Deepa M Gopal, Deirdre M Mooney, et al.
Breast Cancer Research and Treatment|February 23, 2026
Prognostic significance of circulating tumor DNA in early breast cancer: a systematic review and meta-analysisL Sisca, M G Polito, M Silletta, et al.
Oncogene|August 28, 2024
S-p-bromobenzyl-glutathione cyclopentyl diester (BBGC) as novel therapeutic strategy to enhance trabectedin anti-tumor effect in soft tissue sarcoma preclinical modelsF Pantano, S Simonetti, M Iuliani, et al.
Pageof 8